What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kaplan, 2018, Re: Can long-term LUTS-BPH pharmacological treatment alter the outcomes of surgical intervention, J Urol, 199, 6, 10.1016/j.juro.2017.09.130
Mamoulakis, 2014, A plea for higher-quality data for GreenLight laser technology in the context of surgical benign prostatic obstruction trials: the GOLIATH study—fact or fiction in the era of evidence-based urology?, Eur Urol, 65, 943, 10.1016/j.eururo.2013.11.037
Reddy, 1988, Balloon dilatation of the prostate for treatment of benign hyperplasia, Urol Clin North Am, 15, 529, 10.1016/S0094-0143(21)01600-1
Keane, 1990, Balloon dilatation of the prostate: technique and early results, Br J Urol, 65, 354, 10.1111/j.1464-410X.1990.tb14755.x
Schulman, 1995, Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience, Urology, 45, 28, 10.1016/S0090-4295(95)96260-3
Holmes, 1999, Transurethral needle ablation of the prostate: outcome at 1 year, J Endourol, 13, 745, 10.1089/end.1999.13.745
Bouza, 2006, Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia, BMC Urol, 6, 14, 10.1186/1471-2490-6-14
Lukacs, 2013, Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: a comprehensive population study, Eur Urol, 64, 493, 10.1016/j.eururo.2013.02.026
Assel, 2019, Guidelines for reporting of statistics for clinical research in urology, Eur Urol, 75, 358, 10.1016/j.eururo.2018.12.014
The Lancet, 2009, Surgical research: the reality and the IDEAL (editorial), Lancet, 374, 1037, 10.1016/S0140-6736(09)61678-0
Knoll, 2018, Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology, Eur Urol, 73, 290, 10.1016/j.eururo.2017.08.016
Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355, i4919, 10.1136/bmj.i4919
Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (updated March 2011). The Cochrane. www.handbook.cochrane.org.
Cornu, 2015, A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update, Eur Urol, 67, 1066, 10.1016/j.eururo.2014.06.017
Gravas, 2018
Karavitakis, 2019, Management of urinary retention in patients with benign prostatic obstruction: a systematic review and meta-analysis, Eur Urol, 75, 788, 10.1016/j.eururo.2019.01.046
MacLennan, 2017, A core outcome set for localised prostate cancer effectiveness trials, BJU Int, 120, E64, 10.1111/bju.13854
Johnston, 2015, Minimally important difference estimates and methods: a protocol, BMJ Open, 5, 10.1136/bmjopen-2015-007953
Barry, 1995, Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?, J Urol, 154, 1770, 10.1016/S0022-5347(01)66780-6
Revicki, 2008, Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, 61, 102, 10.1016/j.jclinepi.2007.03.012
Mamoulakis, 2009, Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials, Eur Urol, 56, 798, 10.1016/j.eururo.2009.06.037
Omar, 2014, Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP), BJU Int, 113, 24, 10.1111/bju.12281